Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Micardis

Micardis
In stock
20mg · 40mg · 80mg
from A$74.21
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$89.05A$74.21
A$2.47 per tablet

In brief

  • Micardis (telmisartan) is supplied in pharmacies and by online retailers worldwide; it is officially a prescription-only medicine in most countries (FDA, EMA, TGA, etc.), although some pharmacies or online vendors may offer it without asking for a prescription—this practice is not recommended.
  • Micardis is used to treat hypertension and to reduce cardiovascular risk in older high‑risk patients; it is an angiotensin II receptor blocker (ARB) that selectively antagonises the AT1 receptor, reducing vasoconstriction and aldosterone‑mediated sodium/water retention.
  • The usual starting dose for adults with hypertension is 40 mg once daily, titrating up to 80 mg once daily if needed; 20 mg tablets are also available for lower doses or titration, and 80 mg is the dose commonly used for cardiovascular risk reduction in older patients.
  • Micardis is administered orally as a tablet (available in 20 mg, 40 mg and 80 mg strengths); it is taken once daily, with or without food, and can be combined in fixed‑dose pills with agents such as hydrochlorothiazide.
  • Blood‑pressure lowering effects begin within about 1 hour after dosing, with more noticeable effect over the first few hours and further benefit with continued daily dosing.
  • Telmisartan has a long duration of action—effective for about 24 hours—supporting once‑daily dosing for maintenance of blood pressure control.
  • Avoid excessive alcohol while taking Micardis because alcohol can enhance blood‑pressure lowering effects and increase the risk of dizziness and fainting; moderate alcohol may also worsen side effects.
  • The most common side effect reported is back pain; other frequent mild effects include nasal congestion, sinus pain, upper respiratory infection symptoms and diarrhoea, with occasional headache, dizziness or fatigue.
  • Would you like to try micardis without a prescription?

Basic Micardis Information

  • INN (International Nonproprietary Name): Telmisartan.
  • Brand Names Available In Australia: Micardis tablets 20 mg, 40 mg and 80 mg (Boehringer Ingelheim) and various generics.
  • ATC Code: C09CA07 (Angiotensin II receptor blockers, plain).
  • Forms & Dosages: Oral tablets available in 20 mg, 40 mg and 80 mg strengths; local packaging may include blister packs of 14, 28, 30 or 60 tablets.
  • Manufacturers In Australia: Originator Boehringer Ingelheim; generic suppliers include Teva, Sandoz and others.
  • Registration Status In Australia: TGA approved for hypertension and cardiovascular risk reduction.
  • OTC / Rx Classification: Prescription Only (Rx) in Australia.

Critical Warnings & Restrictions (Safety-First)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who needs extra protection when starting telmisartan is a common question.

Telmisartan is contraindicated in pregnancy, especially in the second and third trimesters, because of known fetal risk.

Do not use telmisartan if there is a known allergy to telmisartan or any excipients in the tablet.

Elderly patients require renal function and electrolyte monitoring because they may be more sensitive to hypotension and hyperkalaemia.

Patients with renal impairment need close monitoring of creatinine and potassium and should generally avoid dual RAAS blockade, for example combining telmisartan with aliskiren in diabetes or moderate–severe renal impairment.

  • Absolute Contraindications: Known hypersensitivity to telmisartan or excipients; pregnancy (2nd/3rd trimester); severe hepatic impairment with cholestasis or biliary obstruction; concomitant use with aliskiren in patients with diabetes or moderate–severe renal impairment.
  • Relative Contraindications/Precautions: Mild–moderate hepatic impairment (start lower); renal artery stenosis or prior kidney dysfunction; baseline hyperkalaemia or hyponatraemia; elderly patients (monitor closely).

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Telmisartan can cause dizziness, headache or fatigue, particularly when treatment starts or the dose increases.

Patients should assess their tolerance before driving or operating heavy machinery.

Advise caution for anyone in safety‑critical roles until they know how telmisartan affects them.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Usually yes, but only if you feel alert and stable after taking telmisartan.

If you feel dizzy, light‑headed or sleepy after starting or increasing the dose, do not drive or operate heavy machinery.

For safety‑critical employment, consult the prescriber or pharmacist and document any driving restrictions in line with Australian workplace guidance.

Usage Basics

INN, Brand Names Available In Australia

INN
Telmisartan.
Brand
Micardis (tablets 20 mg, 40 mg, 80 mg) and generics supplied by various manufacturers.
Forms
Tablets only; oral use in 20 mg, 40 mg and 80 mg strengths.

Micardis is prescribed for hypertension and for cardiovascular risk reduction in selected patients.

Legal Classification (TGA‑Approved, PBS Considerations)

Telmisartan is TGA approved and is prescription only in Australia.

PBS subsidy status can change and varies by formulation and combination products, so confirm current listing before assuming concession pricing.

  • Confirm Prescription: Take a valid prescription to the pharmacist or use a legitimate e‑prescription.
  • Check PBS: Ask the pharmacist to verify current PBS subsidy and restrictions.
  • Pharmacist Counselling: Expect counselling on dosing, interactions and monitoring.
  • Allergies: Declare any drug allergies before supply.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical adult initiation is 40 mg once daily for hypertension.

Titrate to 80 mg once daily if blood pressure response is inadequate.

An 80 mg once‑daily regimen is commonly used for cardiovascular risk reduction in older high‑risk patients.

Once‑daily dosing improves adherence for patients taking telmisartan tablets such as Micardis 40 mg or 80 mg.

Adjustments For Comorbidities

Elderly patients do not usually need an initial dose reduction but require renal function monitoring.

In mild to moderate hepatic impairment start at lower doses; telmisartan is not recommended in severe hepatic cholestasis or biliary obstruction.

Renal impairment requires monitoring of creatinine and potassium and avoidance of dual RAAS blockade.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless the next scheduled dose is near.

Do not double up to make up a missed dose.

If vomiting occurs after a dose or in the event of overdose, seek emergency department care for supportive management.

  • Start Dose: 40 mg once daily for most adults.
  • Titrate Step: Reassess blood pressure after 2–4 weeks before increasing to 80 mg.
  • Monitoring Schedule: Check BP and electrolytes at baseline, 2–4 weeks after start or dose change, then periodically.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

No major food interactions are reported for telmisartan tablets.

Alcohol may increase the risk of hypotension and dizziness, especially in older patients or those on multiple antihypertensives.

Food/Drink Effect Advice
Alcohol May potentiate low blood pressure and dizziness Advise moderation; avoid heavy drinking when starting or increasing dose
Coffee/Caffeine No major interaction No specific restrictions; monitor symptoms
High‑potassium Foods Can contribute to hyperkalaemia when combined with telmisartan Advise moderation if on potassium‑sparing diuretics or supplements

Common Drug Conflicts

Key interacting medicines include potassium supplements, potassium‑sparing diuretics, NSAIDs and dual RAAS agents.

These interactions increase the risk of hyperkalaemia or reduce renal function and blood pressure control.

  • Stop/Review Interacting Meds: Review potassium supplements and NSAID use with prescriber.
  • Measure K+ And Creatinine: Check electrolytes and renal function at baseline and after changes.
  • Counsel Patient: Discuss OTC NSAIDs and herbal products that may affect kidneys or potassium.

User Reports & Trends (Australian Patient Feedback)

What do Australians typically report about telmisartan and Micardis in pharmacies and forums?

Consumer and pharmacy feedback in Australia commonly notes mild adverse effects such as dizziness, back pain and nasal congestion.

Cough is reported less often with telmisartan than with ACE inhibitors, aligning with known class differences.

Diarrhoea and occasional headache or fatigue are listed among common tolerability complaints.

Reporting bias exists for online reviews, so formal adverse event reports to the TGA are important for safety monitoring.

  • Common Tolerability Themes: Low incidence of cough, occasional dizziness, mild gastrointestinal symptoms.
  • Adherence Drivers: Once‑daily dosing and tolerability improve persistence with therapy.
  • Price Sensitivity: Cost differences between brand Micardis and generics affect choice for some patients.

Clinicians should consult product information and registry data rather than social forums alone when making decisions.

Pharmacy counselling plays a key role in addressing adherence in rural and culturally diverse communities.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Micardis and telmisartan generics are obtainable from major pharmacy chains and independent pharmacies in Australia.

Supply may also follow public hospital discharge prescriptions where appropriate.

Pharmacy Chain Typical Availability PBS/Subsidy Note
Chemist Warehouse Common stock of generics and brand where supplied Check PBS for subsidy; private prices vary
Priceline Usually stocked or available to order Pharmacist can confirm PBS eligibility
TerryWhite Chemmart Available through network pharmacies and scripts Check PBS and concession entitlements

Online Pharmacies And Telehealth E‑Prescriptions

Legitimate online pharmacies in Australia accept e‑prescriptions and supply telmisartan with pharmacist counselling.

Verify TGA registration and pharmacy accreditation when ordering online and avoid unregulated international sources.

  • Verify Prescription: Ensure a valid prescription or authorised e‑prescription is supplied.
  • Check Packaging: Confirm original packaging and batch details on arrival.
  • Keep Originals: Retain prescription records and packaging for future reference.
  • Monitor Storage During Shipping: Ensure ambient conditions are maintained, especially in hot weather.

In our online pharmacy, micardis is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

Telmisartan is an angiotensin II receptor blocker acting mainly at the AT1 receptor.

Blocking AT1 reduces vasoconstriction and aldosterone secretion, which lowers blood pressure and helps reduce cardiovascular risk.

The ATC code for telmisartan is C09CA07, classifying it among plain ARBs used for blood pressure management.

Mechanism
AT1 receptor antagonist reducing vasoconstriction and aldosterone effects.
Onset
Oral onset is within hours; clinical effect assessed over days to weeks.
Half‑Life/Duration
Long duration of action and high permeability support once‑daily dosing.

Clinical Terms

Because telmisartan binds the receptor for a prolonged period once‑daily dosing is effective for most patients.

Minimal food interactions make dosing flexible with meals and daily routines.

  • Clinical Implication: Suitable when ACE inhibitors are not tolerated, e.g., cough with ACEi.
  • Patient Counselling Language: “Take one tablet daily, usually in the morning, and report any lightheadedness or muscle pain.”
  • Combination Use: Telmisartan is available in single‑pill combos with hydrochlorothiazide when additive blood pressure control is needed.

Indications & Off‑Label Uses

Approved Indications By TGA

Telmisartan is approved for the treatment of hypertension in adults to reduce the risk of stroke and myocardial infarction.

It is also indicated for cardiovascular risk reduction in patients aged 55 years and older at high risk because of diabetes or vascular disease.

Indication Typical Dose Notes
Hypertension (Adults) Start 40 mg once daily; titrate to 80 mg if needed Long‑term therapy for BP control
Cardiovascular Risk Reduction (≥55 years) 80 mg once daily Used where indicated to reduce stroke/MI risk

Off‑Label Uses In Australian Practice

Some clinicians use ARBs like telmisartan to reduce proteinuria in chronic kidney disease under specialist guidance.

Single‑pill combinations with hydrochlorothiazide are commonly used to improve adherence, though PBS listings differ by formulation.

  • Confirm Evidence Basis: Discuss clinical rationale and document informed consent for off‑label use.
  • Check Renal Function: Monitor creatinine and potassium before and after starting ARB therapy.
  • Document Consent: Record specialist advice and monitoring plans in clinical notes.

Key Clinical Findings (2022–2026 Focus)

Recent evidence up to 2026 continues to support telmisartan’s role within the ARB class for blood pressure reduction and cardiovascular protection.

Meta‑analyses and registry data show comparable efficacy across ARBs and a lower cough incidence than ACE inhibitors.

Randomised controlled trials, systematic reviews and observational registries are the main sources that inform guideline updates.

  • Study Types To Include: Randomised controlled trials demonstrating BP lowering and cardiovascular outcomes.
  • Meta‑Analyses: Pooled analyses comparing ARB tolerability and efficacy versus ACE inhibitors.
  • Observational Registries: Real‑world data on adherence, switching and adverse events in primary care and cardiology cohorts.
  • Guideline Updates: National guidance from RACGP and the Heart Foundation should be consulted for current recommendations.

Reference TGA product information and major cardiology guidelines when counselling patients or making prescribing decisions.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Typical Strengths Typical Dose Side‑Effect Profile PBS/Cost Note
Telmisartan (Micardis) 20 mg, 40 mg, 80 mg 40–80 mg once daily Good tolerability; dizziness, back pain, nasal congestion Brand and generics available; check PBS for current subsidy
Losartan (Cozaar) 50 mg, 100 mg 50–100 mg once daily Similar ARB tolerability; rare cough PBS‑listed formulations exist; compare cost with generics
Valsartan (Diovan) 80 mg, 160 mg 80–160 mg once daily Comparable ARB side‑effect profile Check PBS for formulation and subsidy
Irbesartan 75 mg, 150 mg 150–300 mg once daily Typical ARB adverse events PBS listings vary by brand and pack size

Pros And Cons Checklist

  • Pros: Once‑daily dosing supports adherence and telmisartan is generally well tolerated compared with ACE inhibitors for cough.
  • Cons: Contraindicated in pregnancy and carries hyperkalaemia and renal monitoring requirements.
  • Suitability: Choose ARB according to comorbidities, cost, PBS status and patient preference.

Common Questions (Pharmacy Consultations)

These are short pharmacist‑friendly answers for the most common patient questions about telmisartan.

  • What Is The Starting Dose? “Most adults start telmisartan 40 mg once daily; your prescriber will tell you if a different dose is needed.”
  • When Will Blood Pressure Improve? “Expect measurable changes within 1–2 weeks and reassessment at 2–4 weeks.”
  • When To Seek Urgent Care? “Get urgent help for angioedema, severe dizziness, fainting, or very low urine output.”
  • How Often Should Labs Be Checked? “Baseline electrolytes and creatinine, then 2–4 weeks after starting or dose change, then as clinically indicated.”
  • Can I Take OTC Pain Relief? “Use of NSAIDs may reduce BP control and increase kidney risk; discuss alternatives if possible.”
  • What About Pregnancy? “Telmisartan must not be used in pregnancy; discuss contraception and alternative therapy with your prescriber.”
  • What If I Have Muscle Pain? “Report muscle pain or weakness promptly; rhabdomyolysis is very rare but needs assessment.”
  • Are There Herbal Interactions? “Check with the pharmacist as some herbal products can affect electrolytes or BP control.”
  • How Should I Store It? “Keep in the original blister, away from moisture and heat, at 15–30°C.”
  • Follow‑Up Timing? “Book a BP and lab review 2–4 weeks after initiation or dose change and then regularly.”

Use culturally appropriate phrasing and interpreters where needed, and consider rural access challenges when arranging follow‑up.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Out‑Of‑Pocket PBS? Notes
Chemist Warehouse Varies by generic vs brand May apply depending on item Pharmacist can confirm current price and PBS eligibility
Priceline Varies Check PBS Often available to order in store
TerryWhite Chemmart Varies Check PBS Pharmacist counselling available
Hospital Discharge Script Depends on hospital processes May be PBS subsidised Supply arranged on discharge by hospital pharmacy
Online Pharmacies Private price or subsidised depending on prescription Check item and supplier Verify TGA registration and accreditation

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm Valid Prescription: Always required in Australia for telmisartan supply via legitimate channels.
  • Pharmacist Stock Levels: Ask the pharmacy to reserve or order if not in stock.
  • Rural Delivery Time: Allow extra time for postal or courier delivery to remote areas.
  • Pack Sizes: Blister packs commonly come in 14, 28, 30 or 60 tablets depending on supplier.

Registration & Regulation

TGA Approval

Telmisartan (Micardis) is approved by the TGA for hypertension and cardiovascular risk reduction consistent with the product information.

Prescribers and pharmacists should consult the TGA approved product information for up‑to‑date indications and safety data.

PBS Subsidy Details

PBS listing and subsidy vary with formulation, combination products and patient category, so always verify the current PBS schedule for item numbers and restrictions.

  • Verify TGA ARTG Number: Check ARTG if needed for regulatory confirmation.
  • Check Product Information: Use TGA and sponsor product information for dosing and contraindications.
  • Lookup PBS Schedule: Confirm current subsidy and co‑payment amounts online or with the pharmacist.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store telmisartan tablets at controlled room temperature, ideally between 15–30°C.

Keep tablets in the original blister until immediately before use to protect from moisture and light.

Avoid storing medicines in bathrooms or in direct sunlight, particularly during hot and humid Australian summers.

Cold‑Chain Handling For Pharmacies

Telmisartan is not a cold‑chain product and does not require refrigeration.

Pharmacies and couriers should avoid prolonged exposure to high temperatures during transport, especially in summer postal transit.

  • Temperature Limits: Store within recommended room temperature range.
  • Discard If Damaged: Do not use medication if blister is moisture‑damaged or tablets are discoloured.
  • Child Safety: Keep out of reach of children and pets.

Guidelines For Proper Use (Pharmacist Counselling)

Australian Pharmacist Counselling Style

Use plain language and one key message per visit when counselling about telmisartan.

Explain the purpose: “This lowers your blood pressure and helps reduce the risk of stroke and heart attack.”

Cover dosing timing, missed dose action, common side effects and when to seek help.

  • Counselling Steps: Confirm identity and prescription, explain indication, give dosing instructions, review interactions, arrange monitoring and follow‑up.
  • Patient Handout Template: “Take one tablet daily; baseline blood tests due; report dizziness, swelling of face or lips, muscle pain.”

Patient Advice From PBS And National Health Authorities

Provide written information and advise patients to report adverse events to the TGA.

Recommend clinic follow‑up for BP and labs 2–4 weeks after initiation or dose change and regular reviews thereafter.

  • Follow‑Up Checklist: Baseline labs, 2–4 week review, periodic monitoring, and yearly medication review.
  • Shared Decision Making: Discuss benefits, risks and alternatives and document the plan.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Townsville Queensland 14-21 days
Ballarat Victoria 14-21 days
Bendigo Victoria 14-21 days
Albury New South Wales 14-21 days

Related products